BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24813809)

  • 1. Is postoperative adjuvant chemoradiotherapy efficacious and safe for gastric cancer patients with D2 lymphadenectomy? A meta-analysis of the literature.
    Liang JW; Zheng ZC; Yu T; Wang X; Zhang JJ
    Eur J Surg Oncol; 2014 Dec; 40(12):1614-21. PubMed ID: 24813809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.
    Zhou ML; Kang M; Li GC; Guo XM; Zhang Z
    World J Surg Oncol; 2016 Aug; 14(1):209. PubMed ID: 27502921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection].
    Xia GG; Zhang CH; Wei ZW; Wu Y; He YL
    Zhonghua Wai Ke Za Zhi; 2013 May; 51(5):447-51. PubMed ID: 23958170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent.
    Turanli S; Atalay C; Berberoglu U; Gulben K
    J Cancer Res Ther; 2015; 11(2):369-74. PubMed ID: 26148602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.
    Huang YY; Yang Q; Zhou SW; Wei Y; Chen YX; Xie DR; Zhang B
    PLoS One; 2013; 8(7):e68939. PubMed ID: 23874819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
    Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
    J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
    Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
    Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
    Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.
    Iacovelli R; Pietrantonio F; Maggi C; de Braud F; Di Bartolomeo M
    Crit Rev Oncol Hematol; 2016 Feb; 98():24-8. PubMed ID: 26481953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.
    Yang W; Hu R; Li GC; Zhou ML; Wang Y; Shen LJ; Liang LP; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20170594. PubMed ID: 29927628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials.
    Dai Q; Jiang L; Lin RJ; Wei KK; Gan LL; Deng CH; Guan QL
    J Surg Oncol; 2015 Mar; 111(3):277-84. PubMed ID: 25273525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis.
    Cao J; Qi F; Liu T
    Scand J Gastroenterol; 2014 Jun; 49(6):690-704. PubMed ID: 24731211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
    Sun P; Xiang JB; Chen ZY
    Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
    Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
    Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.